(Reuters) -Swiss drugmaker Idorsia said on Monday it has received the U.S. Food and Drug Administration's approval for its treatment for insomnia in adult patients. The drug, to be available under the ...

Pretty much everyone has heard of sleepwalking – and some of us even do it from time to time. But sleep cooking and sleep driving? Engaging in such activities while not awake – a phenomenon known as ...

Turning Any Medication into a Precision AI-Combo Drug through Simple QR-Code Integration LAS VEGAS, NV / ACCESS Newswire / January 7, 2026 / WELT, the Samsung spin-off digital‑pharmaceutical company ...

New analysis of a Phase 3 study of daridorexant shows that 50 mg improved both sleep and daytime functioning compared to placebo in women during ...

The U.S. Food and Drug Administration is asking several drug manufacturers to strengthen product warning labels for many sleep medications because of risks that people will do things they don’t ...

ATS 2023, Washington, DC – Chronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien, Intermezzo and other ...

Sept. 27, 2012 -- Seniors who take certain kinds of drugs to treat anxiety or insomnia may be more likely to develop dementia than those who do not, a new study shows. Seniors are often prescribed ...

The U.S. Food and Drug Administration today approved Intermezzo (zolpidem tartrate sublingual tablets) for use as needed to treat insomnia characterized by middle-of-the-night waking followed by ...

Persistent sleeplessness stems from a variety of factors, all of which should be addressed if a treatment plan is to succeed long-term. While many patients (10%-40% of the population) complain about ...

It’s not uncommon for people to have issues with sleep. Most will get back to regular sleep patterns sooner rather than later. What if the difficulty with sleep does not stop? What if sleep problems ...

Two drugs have emerged as the optimal medications for treating insomnia based on the "best-available evidence," but there are caveats. In a comprehensive comparative-effectiveness analysis, ...